Novan Engages Catalent to Develop Intranasal Formulation of Berdazimer Sodium for COVID-19 Program
– Catalent has a proven track record of accelerating molecules from early development through commercial manufacturing – – Company targets...
– Catalent has a proven track record of accelerating molecules from early development through commercial manufacturing – – Company targets...
DOYLESTOWN, Pa., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (OTCQB: NPTX), (the “Company” or "Neuropathix"), a socially responsible pain...
– exoIL-12 has demonstrated tissue-retained pharmacology, enhanced anti-tumor activity, potent M1 myeloid recruitment, and superior T cell responses in vivo...
Transaction Expands Gainwell’s Capabilities as an Analytics-Driven Healthcare Technology Provider Cotiviti to Subsequently Acquire Certain Business Lines, Expanding Health Plan...
Patient recruitment in Phase III trial has surpassed 60% Trial is expanded to Israel with first clinical site at Tel...
NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CannAssist International Corp. (OTCQB: CNSC) ("CannAssist International" or the...
Versamune® T-cell activating platform demonstrates breadth of anti-SARS-CoV-2 immune responses in a COVID-19 vaccine PDS Biotech Announces Mount Sinai Publication...
DAVIS, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Farmers in Uruguay will have a new solution to grow a more...
NEW YORK and SYDNEY, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”),...
WARSAW, Ind., Dec. 21, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively...
- Early Data from Study of GPS in Combination with Keytruda® in Patients with Advanced WT1(+) Ovarian Cancer Shows Disease...
PRESS RELEASE December 21, 2020 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the...
Company announcement, Helsinki, 21 December 2020 at 15.15 (EET) Nexstim Plc’s Financial Information in 2021 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim"...
Dravet syndrome is a rare, debilitating and difficult-to-treat lifelong epilepsy that begins in infancyEC approval is based on Phase 3...
MIAMI, Dec. 21, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment of Roger Medel, M.D....
– Comparison of 10 AllocetraTM-treated patients with 37 matched controls showed significant positive responses in state of organ failure, duration...
CAMBRIDGE, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline...
Equillium Further Strengthens Management Team with Additional Executive HiresLA JOLLA, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq:...
OREM, Utah, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), is a provider of diverse products and...
Company affirms plans to begin enrollment of patients with HR+ HER2- metastatic breast cancer and other tumors in U.S. Phase...